Early recanalization and plasma brain natriuretic peptide as an indicator of left ventricular function after acute

Teruo Inoue1, Masashi Sakuma, Isao Yaguchi

  • 1Department of Cardiology, Koshigaya Hospital, Dokkyo University School of Medicine, Saitama, Japan.

Insights

Plasma brain natriuretic peptide (BNP) levels measured early after acute myocardial infarction (AMI) can predict long-term heart function. Early artery reopening influences BNP levels and cardiac outcomes.

Area of Science:

  • Cardiology
  • Biomarkers
  • Myocardial Infarction

Background:

  • Plasma brain natriuretic peptide (BNP) levels are measured in acute myocardial infarction (AMI) but their relation to early recanalization and chronic cardiac function is unclear.
  • This study aimed to clarify the role of BNP in predicting left ventricular function after AMI.

Purpose of the Study:

  • To determine if early recanalization in AMI modulates plasma BNP levels.
  • To assess the predictive value of plasma BNP levels for chronic-stage left ventricular function.

Main Methods:

  • Plasma BNP levels were measured in 80 AMI patients at admission, 4, 24, 48 hours, and 1 month post-admission.
  • Patients were categorized into groups based on infarct-related artery patency within 6 hours of MI onset.

Main Results:

  • Patients with a 6-hour occlusion had significantly higher BNP levels at 4, 24, and 48 hours compared to those with 6-hour patency.
  • Chronic left ventricular function correlated with BNP levels at various time points, notably at 24 and 48 hours.
  • BNP levels at 24 hours post-admission were identified as the strongest predictor of chronic left ventricular function.

Conclusions:

  • Plasma BNP levels are predictive of subsequent cardiac function in AMI patients.
  • BNP kinetics may support the importance of early recanalization in AMI management.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...